STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

AGNC Form 4: CEO executes 10b5-1 sales near $10.30

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

AGNC Investment Corp. (AGNC) reported insider transactions on a Form 4. The reporting person, a Director and the company’s President, CEO and CIO, sold common stock in three open-market trades pursuant to a Rule 10b5-1 plan adopted on May 14, 2025.

Sales were 45,797 shares at a weighted-average price of $10.157 on 10/24/2025, 45,798 shares at $10.267 on 10/27/2025, and 45,798 shares at $10.2976 on 10/28/2025. Following these transactions, beneficial ownership stood at 1,511,602.869 shares directly, plus 1,900 shares held indirectly in an IRA. The filing notes 54,242 dividend equivalent restricted stock units included since the last report.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Federico Peter J

(Last) (First) (Middle)
AGNC INVESTMENT CORP.
7373 WISCONSIN AVE 22ND FL

(Street)
BETHESDA MD 20814

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AGNC Investment Corp. [ AGNC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Director, Pres., CEO and CIO
3. Date of Earliest Transaction (Month/Day/Year)
10/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/24/2025 S 45,797(1) D $10.157(2) 1,603,198.869(3) D
Common Stock 10/27/2025 S 45,798(1) D $10.267(4) 1,557,400.869 D
Common Stock 10/28/2025 S 45,798(1) D $10.2976(5) 1,511,602.869 D
Common Stock 1,900 I IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025.
2. The reported price is a weighted average. The shares were sold in multiple transactions at prices ranging from $10.150 to $10.160, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3. Includes 54,242 dividend equivalent restricted stock units received on previously granted RSU awards since the Reporting Person's last Form 4 filing.
4. The reported price is a weighted average. The shares were sold in multiple transactions at prices ranging from $10.245 to $10.300, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
5. The reported price is a weighted average. The shares were sold in multiple transactions at prices ranging from $10.29 to $10.31, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Peter Federico 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did AGNC (AGNC) disclose?

A Director and the President, CEO and CIO reported three open-market sales of common stock on 10/24/2025, 10/27/2025, and 10/28/2025.

How many AGNC shares were sold and at what prices?

45,797 shares at $10.157 on 10/24/2025, 45,798 shares at $10.267 on 10/27/2025, and 45,798 shares at $10.2976 on 10/28/2025 (weighted averages).

Was the AGNC insider trading under a Rule 10b5-1 plan?

Yes. The sales were effected under a Rule 10b5-1 trading plan adopted on May 14, 2025.

What is the insider’s remaining AGNC share ownership?

After the reported transactions, the insider beneficially owned 1,511,602.869 shares directly and 1,900 shares indirectly in an IRA.

What are the dividend equivalent RSUs mentioned for AGNC?

The filing states 54,242 dividend equivalent restricted stock units were received on previously granted RSU awards since the last report.
Agnc Invt Corp

NASDAQ:AGNC

AGNC Rankings

AGNC Latest News

AGNC Latest SEC Filings

AGNC Stock Data

11.05B
1.07B
0.37%
43.1%
5.76%
REIT - Mortgage
Real Estate Investment Trusts
Link
United States
BETHESDA